Belizna, C. Et Al. 2018. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. AUTOIMMUNITY REVIEWS , vol.17, no.12 , 1153-1168.

Belizna, C., Pregnolato, F., Abad, S., Alijotas-Reig, J., Amital, H., Amoura, Z., ... Andreoli, L.(2018). HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. AUTOIMMUNITY REVIEWS , vol.17, no.12, 1153-1168.

Belizna, Cristina Et Al. "HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome," AUTOIMMUNITY REVIEWS , vol.17, no.12, 1153-1168, 2018

Belizna, Cristina Et Al. "HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome." AUTOIMMUNITY REVIEWS , vol.17, no.12, pp.1153-1168, 2018

Belizna, C. Et Al. (2018) . "HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome." AUTOIMMUNITY REVIEWS , vol.17, no.12, pp.1153-1168.

@article{article, author={Cristina Belizna Et Al. }, title={HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome}, journal={AUTOIMMUNITY REVIEWS}, year=2018, pages={1153-1168} }